WHO ICTRP trial
To compare bupivacaine and ropivacaine in for post-operative pain relief after…
CTRI/2021/12/038898 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/12/038898 |
|---|---|
| Public title | To compare bupivacaine and ropivacaine in for post-operative pain relief after Elective Abdominal Hysterectomy. |
| Scientific title | Comparison of Ropivacaine (0.75%) and Bupivacaine (0.5%) in bilateral transversus abdominis plane block for post-operative analgesia in Elective Abdominal Hysterectomy under Sub-arachnoid block |
| Primary sponsor | Government medical collegeBhavnagar |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: N92- Excessive, frequent and irregularmenstruation Health Condition 2: D25- Leiomyoma of uterus Health Condition 3: O- Medical and Surgical Health Condition 4: N93- Other abnormal uterine and vaginalbleeding |
| Interventions | Intervention1: INJ BUPIVACAINE: INJ BUPIVACAINE(0.50%) DOSE 15ml on each side (total 30ml) frequency : single dose route : intramuscular Control Intervention1: INJ ROPIVACAINE: INJ ROPIVACAINE(0.75%) DOSE 15ml on each side (total 30ml)… |
| Registration date | Dec 24, 2021 |
| Target size | 64 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: